26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

402<br />

Chapter | 13 Hepatic Function<br />

FIGURE 13-11 Phenolsulfonphthalein (PSP) is a dye that is cleared<br />

exclusively by the kidney and used in renal function tests.<br />

Sulfobromophthalein (BSP) is closely related structurally, but the modifications<br />

result in excretion almost entirely by the liver and its use in<br />

assessment <strong>of</strong> hepatic function.<br />

intravenous injection <strong>of</strong> ICG. Three plasma samples are<br />

usually taken between 3 and 15 min after administration<br />

and the ICG concentration measured spectrophotometrically.<br />

It also is possible to estimate plasma volume and<br />

hepatic blood flow ( Ketterer et al., 1960 ). Normal ICG<br />

plasma T ½ and K values for the dog using 0.5 mg/kg ICG<br />

(0.64 μ mol/kg) were reported to be 8.4 2.3 min and<br />

0.089 0.027/minute ( Bonasch and Cornelius, 1964 ).<br />

Using an ICG dose <strong>of</strong> 1.0 mg/kg (1.3 μ mol/kg), Center et<br />

al. (1983c) reported an ICG T ½ for dogs <strong>of</strong> 9.0 2.0 min,<br />

a clearance rate 3.7 0.7 ml/min/kg, and a 30-min retention<br />

<strong>of</strong> 14.7 5.0%. In cats that received an ICG dose<br />

<strong>of</strong> 1.5 mg/kg, Center et al. (1983b) reported a T ½ <strong>of</strong><br />

3.8 0.9 min, a clearance rate <strong>of</strong> 8.6 4.1, and 30-min<br />

retention <strong>of</strong> 7.3 2.9%. Using an ICG dose <strong>of</strong> 0.5mg/kg<br />

(0.64 μ mol/kg) in sheep, Sato (1984) reported a T 1/2 <strong>of</strong><br />

4.8 0.5 min, and for heifers using a dose <strong>of</strong> 0.75 mg/kg<br />

(0.97 μ mol/kg), the T ½ was 3.5 0.8 min.<br />

V . OVERVIEW AND CONCLUSIONS<br />

FIGURE 13-12 Calculation <strong>of</strong> T ½ for sulfobromophthalein (BSP) in the<br />

horse. After bolus injection intravenously, serum samples were obtained at<br />

6 and 10 min, and the T ½ was calculated to be 2.5 min (normal).<br />

plasma is measured after the intravenous injection <strong>of</strong> bolus<br />

doses <strong>of</strong> dye ( Warren et al., 1984 ). Because disappearance<br />

<strong>of</strong> the dye from plasma follows Michaelis-Menten kinetics,<br />

Lineweaver-Burke analysis provides apparent K m and V max<br />

values for the removal <strong>of</strong> ICG ( Paumgartner et al., 1970 ).<br />

The maximal dye removal capacity can be estimated from<br />

a small number <strong>of</strong> submaximal clearance values. Although<br />

such multiple tests are not useful for routine practice, they<br />

provide clinical investigators a sensitive index <strong>of</strong> hepatic<br />

dye clearance that is independent <strong>of</strong> blood flow.<br />

For clinical application liver function test as a T ½<br />

and fractional clearance (K) is determined after a single<br />

Conventional tests for hepatic disease provide information<br />

about the integrity <strong>of</strong> the hepatocytes (ALT, AST, SDH)<br />

and the status <strong>of</strong> the biliary system (AP, GGT). Hepatic<br />

function can be assessed by estimating the excretory<br />

capacity (bilirubin, bile acids NH 3 ) and synthetic functions<br />

(NH 3 /urea, albumin, fibrinogen, and prothrombin) <strong>of</strong> the<br />

liver.<br />

For the results <strong>of</strong> clinical laboratory tests to be <strong>of</strong> optimal<br />

value, it is essential that the specific purpose(s) <strong>of</strong> the<br />

test(s) being performed be defined. Tests for hepatic disease<br />

are performed for a variety <strong>of</strong> purposes including to<br />

confirm the existence <strong>of</strong> liver disease, to assess the nature<br />

(e.g., hepatocellular injury, cholestasis) and severity <strong>of</strong><br />

the disease to determine prognosis, to monitor the clinical<br />

course and response to therapy, and to screen individuals at<br />

risk for the existence <strong>of</strong> occult liver disease.<br />

Many <strong>of</strong> the standard tests for liver disease are based<br />

on rather simple biochemical procedures that have been<br />

automated for use in multichannel autoanalyzers. One seldom<br />

obtains the result <strong>of</strong> a single test for liver disease but<br />

rather a panel <strong>of</strong> results or a “ liver pr<strong>of</strong>ile. ” In some situations,<br />

the results <strong>of</strong> multiple tests <strong>of</strong> liver injury and function<br />

may be received even when there is no specific clinical<br />

indication for them because, with autoanalyzers, it may be<br />

more efficient to perform a large series <strong>of</strong> tests than to be<br />

selective.<br />

In a given population <strong>of</strong> animals, some will have liver<br />

disease and some will not. If a test is applied to the whole<br />

population, a certain number <strong>of</strong> those with the disease will<br />

have a positive test result (true positives), and some with<br />

the disease will have a negative test result (false negatives).<br />

Similarly, among those without the disease, some will have<br />

a positive test result (false positives), and in some, the test

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!